Status:

UNKNOWN

Lung Volume Reduction Coil Treatment in Emphysema.

Lead Sponsor:

CHU de Reims

Collaborating Sponsors:

PneumRx, Inc.

Conditions:

Emphysema

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

* BACKGROUND: Medical therapeutic options for the treatment of emphysema remain limited. Lung volume reduction surgery is infrequently used because of its high morbi-mortality. Endobronchial lung volu...

Eligibility Criteria

Inclusion

  • Bilateral emphysema on Chest CT Scanner
  • Post bronchodilator FEV1 \< 50 %
  • Total Lung Capacity \> 100 %
  • Residual Volume \> 220 %
  • Dyspnea score between 2 and 4 based on the mMRC scale
  • Stopped cigarette smoking for more than 8 weeks
  • Pulmonary rehabilitation within the previous twelve months
  • Consent form signed
  • Covered by Medical Insurance

Exclusion

  • Post bronchodilator FEV1 \< 15%
  • Post-bronchodilator change in FEV1 \> 20%
  • Severe recurrent respiratory infections requiring more than 2 hospitalization stays within the past twelve months
  • COPD exacerbation requiring hospital stay within 3 months
  • Pulmonary Hypertension (Pulmonary systolic pressure \>50 mmHg on cardiac echo)
  • Patient unable to perform a 6-min walking test in room air
  • Giant bulla of more than 1/3 of the lung field on Chest CT
  • Strictly homogeneous emphysema on Chest CT
  • Clinically significant bronchiectasis
  • Past history of lobectomy, lung volume reduction surgery, lung transplantation
  • Any extrapulmonary diseases compromising survival or evaluation within the protocol (severe cardiac disease, severe renal insufficiency, cancer…)
  • Lung carcinoma or pulmonary nodule on CT scan requiring Chest CT scan follow-up
  • Contra-indication to general anesthesia
  • Oral anticoagulant treatment (antivitamin K)
  • Allergy to nitinol
  • Inclusion in an other study assessing respiratory treatments
  • Patient protected by the law

Key Trial Info

Start Date :

March 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2019

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT01822795

Start Date

March 1 2013

End Date

December 1 2019

Last Update

April 30 2014

Active Locations (9)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (9 locations)

1

CHU d'Amiens

Amiens, France, 80054

2

CHU de Grenoble

Grenoble, France, 38043

3

AP-HM

Marseille, France, 13015

4

CHU de Montpellier

Montpellier, France, 34295